
Understanding, Diagnosing, and Using Genetic Testing for Azorean Disease
Azorean Disease, also known as Machado-Joseph Disease (MJD), is a hereditary neurodegenerative disorder that affects muscle control and movement.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Azorean Disease, also known as Machado-Joseph Disease (MJD), is a hereditary neurodegenerative disorder that affects muscle control and movement.

Lumps, nipple discharge and skin dimpling can signal breast cancer in men; BRCA1 and BRCA2 testing informs screening, treatment choices and risk for relatives.

Tangled arteries and veins in the brain can bleed or cause seizures; MRI, CT and cerebral angiography locate them, while genetic testing may show familial risk.

Swelling of the brain can follow head injury, stroke, infection, tumors or high altitude; CT and MRI show its extent, and testing can reveal inherited predispositions.

Damage to the developing brain affects movement, muscle tone and posture; exome sequencing can identify genetic causes of cerebral palsy to guide care.

An abnormal, non-cancerous growth of skin cells behind the eardrum, cholesteatoma can erode middle-ear bones; otoscopy, CT scans and hearing tests find it.

Persistent ear discharge, hearing loss and vertigo point to this growth behind the eardrum, where vertigo may signal labyrinthine fistula; CT and MRI help.

Sinus inflammation lasting more than 12 weeks brings congestion, facial pain and reduced smell; imaging, nasal endoscopy and gene testing are covered.